<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" position="float">
 <label>TABLE 2</label>
 <caption>
  <p>Clinical trials studies of plants with anti-allergic rhinitis.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead valign="top">
   <tr>
    <th align="left" rowspan="1" colspan="1">Plant name</th>
    <th align="center" rowspan="1" colspan="1">Family</th>
    <th align="center" rowspan="1" colspan="1">Country</th>
    <th align="center" rowspan="1" colspan="1">Study design</th>
    <th align="center" rowspan="1" colspan="1">Dosage form</th>
    <th align="center" rowspan="1" colspan="1">Mechanism of action/Subject</th>
    <th align="center" rowspan="1" colspan="1">References</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Artemisia abrotanum</italic> L
    </td>
    <td rowspan="2" align="left" colspan="1">Asteraceae</td>
    <td rowspan="2" align="left" colspan="1">Sweden</td>
    <td rowspan="2" align="left" colspan="1">Open label “proof of concept” study</td>
    <td rowspan="2" align="left" colspan="1">Nasal spray</td>
    <td align="left" rowspan="1" colspan="1">The flavonoid fraction in the nasal spray was likely to inhibit the effects mediated by histamine in the nasal mucosa</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B86" ref-type="bibr">Remberg et al. (2004)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">12 patients with diagnoses of allergic rhinitis, allergic conjunctivitis and/or bronchial obstructive disease. Only 6 patients were being administered with this preparation without concomitant use of other types of antihistamine</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Artemisia annua</italic> L
    </td>
    <td rowspan="2" align="left" colspan="1">Asteraceae</td>
    <td rowspan="2" align="left" colspan="1">China</td>
    <td rowspan="2" align="left" colspan="1">Phase 3, randomized, double-blind, placebo-controlled study</td>
    <td rowspan="2" align="left" colspan="1">Oral liquid</td>
    <td align="left" rowspan="1" colspan="1">Used as immunotherapy. Further studies are needed to identify the immunologic mechanisms involved</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B66" ref-type="bibr">Lou et al. (2020)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Patients with AR were randomized into 2 groups at a ratio of 2:1, sublingual immunotherapy group (
     <italic>n</italic> = 395) and placebo group (
     <italic>n</italic> = 195)
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Astragalus mongholicus</italic> Bunge
    </td>
    <td rowspan="2" align="left" colspan="1">Fabaceae</td>
    <td rowspan="2" align="left" colspan="1">Croatia</td>
    <td rowspan="2" align="left" colspan="1">Double blind, placebo-controlled clinical trial</td>
    <td rowspan="2" align="left" colspan="1">Oral capsule</td>
    <td align="left" rowspan="1" colspan="1">Decreased the expression of IgE, IgG and eosinophils</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B70" ref-type="bibr">Matkovic et al. (2010)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">48 adult outpatient participants of both sexes with a known history of moderate to severe SAR during the grass (
     <italic>n</italic> = 26) or weed pollen season (
     <italic>n</italic> = 22)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Betula lenta</italic> L
    </td>
    <td align="left" rowspan="1" colspan="1">Betulaceae</td>
    <td align="left" rowspan="1" colspan="1">United Kingdom</td>
    <td align="left" rowspan="1" colspan="1">Randomized, placebo-controlled, double-blind, double-dummy study</td>
    <td align="left" rowspan="1" colspan="1">Birch pollen extract</td>
    <td align="left" rowspan="1" colspan="1">Acted by influencing basic immunological mechanisms resulting in the suppression of the seasonal increase in eosinophil, in reduction of the late-phase reactivity. It also initiate and maintain the shift from a Th2- to Th1-like response. 89 patients (mean age 30 years, range 20–58 years) with at least 2 years of seasonal birch pollen rhinoconjunctivitis uncontrolled by conventional pharmacotherapy were enrolled</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B52" ref-type="bibr">Khinchi et al. (2004)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Camellia sinensis</italic> (L.) Kuntze
    </td>
    <td rowspan="2" align="left" colspan="1">Theaceae</td>
    <td rowspan="2" align="left" colspan="1">Japan</td>
    <td rowspan="2" align="left" colspan="1">Open-label, single-dose, randomized, parallel-group study</td>
    <td rowspan="2" align="left" colspan="1">Tea drink</td>
    <td align="left" rowspan="1" colspan="1">
     <bold>S</bold>trongly inhibited mast cell activation through the prevention of tyrosine phosphorylation (Lyn, Syk, and Btk) of cellular protein, myosin light chain phosphorylation, and the expression of FcεRI.
    </td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B67" ref-type="bibr">Maeda- Yamamoto et al. (2009)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">38 subjects with Japanese cedar pollinosis. The subjects were randomly assigned to long-term</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Glycine</italic> max (L.) Merr
    </td>
    <td rowspan="2" align="left" colspan="1">Fabaceae</td>
    <td rowspan="2" align="left" colspan="1">Japan</td>
    <td rowspan="2" align="left" colspan="1">A randomized, double-blind, placebo-controlled parallel group design</td>
    <td rowspan="2" align="left" colspan="1">Oral capsules</td>
    <td align="left" rowspan="1" colspan="1">Inhibited histamine release in animal study</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B58" ref-type="bibr">Kobayashi et al. (2004a)</xref>; 
     <xref rid="B59" ref-type="bibr">Kobayashi et al. (2004b)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Aged 20–60 years, 24 patients with a well-documented history of PAR for the last 2 years, were enrolled</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Nepeta bracteata</italic> Benth
    </td>
    <td rowspan="2" align="left" colspan="1">Lamiaceae</td>
    <td rowspan="2" align="left" colspan="1">Iran</td>
    <td rowspan="2" align="left" colspan="1">A randomized double blind clinical trials</td>
    <td rowspan="2" align="left" colspan="1">
     <italic>Nepeta bracteata</italic> Syrup (NBS)
    </td>
    <td align="left" rowspan="1" colspan="1">Inhibited Ig-E and have anti-allergic activities such as prevention of the expression of CD40 receptor ligand by basophils and inhibition of the release of histamine by interleukin IL-4 and IL-3</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B41" ref-type="bibr">Hajiheydari et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">71 patients completed the trial, 37 patients in treatment, and 34 ones in placebo group</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Nigella sativa</italic> L
    </td>
    <td rowspan="2" align="left" colspan="1">Ranunculaceae</td>
    <td rowspan="2" align="left" colspan="1">Iran</td>
    <td rowspan="2" align="left" colspan="1">Prospective and double blind study with descriptive analytic</td>
    <td rowspan="2" align="left" colspan="1">
     <italic>N. sativa</italic> oil
    </td>
    <td align="left" rowspan="1" colspan="1">Decreased IgE and eosinophil levels</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B75" ref-type="bibr">Nikakhlagh et al., (2011)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">66 patients (case and control) with allergic rhinitis (22 males and 44 females)</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Petasites hybridus</italic> (L.) G.Gaertn., B.Mey. and Scherb
    </td>
    <td rowspan="2" align="left" colspan="1">Asteraceae</td>
    <td rowspan="2" align="left" colspan="1">Switzerland</td>
    <td rowspan="2" align="left" colspan="1">Randomized, double blind, parallel group comparison</td>
    <td rowspan="2" align="left" colspan="1">Oral tablet</td>
    <td align="left" rowspan="1" colspan="1">Inhibited the biosynthesis of leukotrienes, which may be associated with antispasmodic activity and anti-inflammatory action in type I hypersensitivity</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B101" ref-type="bibr">Thomet, et al. (2002)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">131 patients were screened for seasonal allergic rhinitis and 125 patients were randomized (butterbur 61; cetirizine 64)</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1"/>
    <td rowspan="2" align="left" colspan="1"/>
    <td rowspan="2" align="left" colspan="1">United Kingdom</td>
    <td rowspan="2" align="left" colspan="1">A prospective, randomized, double-blind, double-dummy, 3-arm crossover design</td>
    <td rowspan="2" align="left" colspan="1">Petasol butenoate complex (Ze 339)</td>
    <td align="left" rowspan="1" colspan="1">Reduced IL-8 and Leukotriene B
     <sub>4</sub> (LTB
     <sub>4</sub>)
    </td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B33" ref-type="bibr">Dumitru et al. (2011)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">18 healthy adults with at least 2-years medical history of moderate-to-severe AR to grass pollen</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Pinus pinaster</italic> Aiton
    </td>
    <td rowspan="2" align="left" colspan="1">Pinaceae</td>
    <td rowspan="2" align="left" colspan="1">United states</td>
    <td rowspan="2" align="left" colspan="1">A randomized, double-blind, placebo-controlled exploratory study</td>
    <td rowspan="2" align="left" colspan="1">Oral tablets</td>
    <td align="left" rowspan="1" colspan="1">Inhibited expression of proinflammatory cytokine IL-1</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B88" ref-type="bibr">Ross (2016)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">39 healthy patients (
     <italic>n</italic> = 39), male and female, with an age distribution between 18 and 65 years. They were randomized into 2 groups, the Pycnogenol test group (
     <italic>n</italic> = 19) (Manhattan Drug Company, Hillside, New Jersey) or the placebo group (
     <italic>n</italic> = 20) 
     <xref rid="B88" ref-type="bibr">Ross, (2016)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Rubus chingii</italic> var. 
     <italic>suavissimus</italic>(S.K.Lee)
    </td>
    <td rowspan="2" align="left" colspan="1">Rosaceae</td>
    <td rowspan="2" align="left" colspan="1">Japan</td>
    <td rowspan="2" align="left" colspan="1">A randomized double blind study, placebo controlled, clinical trial</td>
    <td rowspan="2" align="left" colspan="1">Oral capsules (ten-Cha extracts)</td>
    <td align="left" rowspan="1" colspan="1">Mast cell stabilizers to inhibit histamine release</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B115" ref-type="bibr">Yonekura et al., 2011</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">L.T.Lu</td>
    <td align="left" rowspan="1" colspan="1">47 of the patients were being administered with the oral extracts while another 42 patients were on placebo</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Urtica dioica</italic> L
    </td>
    <td rowspan="2" align="left" colspan="1">Urticaceae</td>
    <td rowspan="2" align="left" colspan="1">Iran</td>
    <td rowspan="2" align="left" colspan="1">A randomized double blind study, placebo controlled, clinical trial</td>
    <td rowspan="2" align="left" colspan="1">Oral tablets</td>
    <td align="left" rowspan="1" colspan="1">Decreased the production of eosinophil</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B10" ref-type="bibr">Bakhshaee (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">AR patients (
     <italic>n</italic> = 40), 2 groups of 20 patients each (Urtidin tab against Placebo)
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Vitis vinifera</italic> L
    </td>
    <td rowspan="2" align="left" colspan="1">Vitaceae</td>
    <td rowspan="2" align="left" colspan="1">United states</td>
    <td rowspan="2" align="left" colspan="1">Double-blind randomized control study</td>
    <td rowspan="2" align="left" colspan="1">Grapeseed extracts</td>
    <td align="left" rowspan="1" colspan="1">GSE contains catechin monomers which have been demonstrated to inhibit allergeninduced histamine release in passively sensitized rat peritoneal mast cells</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B15" ref-type="bibr">Bernstein et al. (2002)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Patients with SAR and skin prick test sensitivity to ragweed were randomized to 8 weeks of active treatment or placebo which was begun before the ragweed pollen season</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Zataria multiflora</italic> Boiss
    </td>
    <td rowspan="2" align="left" colspan="1">Lamiaceae</td>
    <td rowspan="2" align="left" colspan="1">Iran</td>
    <td rowspan="2" align="left" colspan="1">Double-blind randomized control study</td>
    <td rowspan="2" align="left" colspan="1">Diluted 20% ZM hydro alcoholic extract</td>
    <td align="left" rowspan="1" colspan="1">Decreased the expression of IL-7</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B3" ref-type="bibr">Ariaee et al. (2018)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">AR patients (
     <italic>n</italic> = 30), 17 female 13 male
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">
     <italic>Zingiber montanum </italic>(J.Koenig) Link ex A.Dietr
    </td>
    <td rowspan="2" align="left" colspan="1">Zingiberaceae</td>
    <td rowspan="2" align="left" colspan="1">Thailand</td>
    <td rowspan="2" align="left" colspan="1">Randomized, open-label, threeway crossover study</td>
    <td rowspan="2" align="left" colspan="1">Oral capsule</td>
    <td align="left" rowspan="1" colspan="1">Inhibited protein synthesis and phorbol 12-myristate 13-acetate-induced MMP-9 gene expression and in human airway epithelial cells, and suppresses MMP-9 cleavage by house dust mites</td>
    <td rowspan="2" align="left" colspan="1">
     <xref rid="B100" ref-type="bibr">Tanticharoenwiwat et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">20 allergic rhinitis patients (14 women and 6 men). There were 12 patients with mild intermittent allergic rhinitis, 5 patients with mild persistent allergic rhinitis and 3 patients with severe persistent allergic rhinitis</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
